Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Chronic Kidney Failure
Interventions
DRUG

Fermagate

Film coated tablet 500mg

DRUG

Sevelamer HCl

tablet 800mg

Trial Locations (15)

DE22 3NE

Department of Renal Medicine, Derby City General Hospital, Uttoxeter Road, Derby

RM7 0AG

Queens Dialysis Unit, Rom Valley Way, Romford

B15 2TH

Renal Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham

CV2 2DX

Ash Haemodialysis Unit, Hospital of St Cross, University Hospital of Coventry & Warwickshire NHS Trust, Clifford Bridge Road, Coventry

Haemodyialysis unit, Department of Nephrology, Walsgrave Hospital, University of Coventry & Warwickshire NHS Trust, Clifford Bridge Road, Coventry

G11 6NT

Renal Dialysis Unit, Western Infirmary, Dumbarton Road, Glasgow

G12 0XP

Renal Dialysis Unit, Gartnavel General Hospital, Glasgow

E1 1BB

Renal Unit, The Royal London Hospital, Whitechapel, London

E11 1 NR

Whipps Cross Renal Unit, Whipps Cross University Hospital, Whipps Cross Road, Leytonstone, London

E11 2PU

Wanstead Renal Unit, 29 Cambridge Park, Wanstead, London

EC1A 7BE

Renal Unit, St Bartholomew's Hospital, West Smithfield, London

M13 9WL

Central Manchester & Manchester Childrens Hospital NHS Trust, Renal Dialysis Unit, Manchester Royal Infirmary, Oxford Rd, Manchester

M23 9LT

Central Manchester & Manchester Childrens Hospital NHS Trust, Renal Dialysis Unit, Wythenshawe Hospital, Southmoor Rd, Manchester

RG1 5AN

Haemodialysis Unit, Royal Berkshire Hospital, Royal Berkshire Hospital, Royal Berkshire NHS Foundation Trust, London Rd, Reading

M6 8HD

Renal Services, Hope Hospital, Salford

All Listed Sponsors
lead

Ineos Healthcare Limited

INDUSTRY

NCT00436683 - Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia | Biotech Hunter | Biotech Hunter